Spondylocladium Allergy Shots: Decoding a Legacy Panel Name and Its SCIT Pathway
Spondylocladium is a legacy mold extract name that persists in allergy catalogs despite modern taxonomy reassigning most isolates to Bipolaris, Drechslera, or related Pleosporaceae genera. A positive Spondylocladium result means Pleosporales sensitization — which routes to the Alternaria SCIT pathway (Kuna 2011, Tabar 2019). No Spondylocladium-specific allergens are WHO/IUIS-registered and no SCIT RCT exists for this genus.
Spondylocladium Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to spondylocladium — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of spondylocladium allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of spondylocladium immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of spondylocladium extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for spondylocladium allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing spondylocladium extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription spondylocladium immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat spondylocladium allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Spondylocladium?
The biology, taxonomy, and clinical fingerprint of Spondylocladium — the foundation of how SCIT targets it.
Spondylocladium is a legacy mold-panel name for dematiaceous Pleosporales fungi now reclassified into Bipolaris, Drechslera, and related modern genera.
- Scientific name
- Spondylocladium atrovirens (now largely synonymized with Helminthosporium / Bipolaris-Drechslera complex in modern taxonomy)
- Family
- Pleosporaceae (historically misclassified)Pleosporales order — Dothideomycetes
- Type
- Legacy-named dematiaceous outdoor hyphomycete; predominantly outdoor saprophyte
- Native to
- Temperate Northern Hemisphere; outdoor saprophyte on decaying vegetation and soil
- Allergen proteins
- No WHO/IUIS-registered Spondylocladium allergens as of 2024Cross-reactivity with Alternaria via Alt a 1 homologues and Alt a 4 (PDI) assumed given Pleosporaceae placement (Twaroch 2012)
- Particle size
- Dematiaceous phragmospores; historically described as dark, multicellular
- Avoidance difficulty
- Very difficult
How Spondylocladium Allergy Presents
Symptoms by body system — useful for distinguishing Spondylocladium sensitivity from overlapping allergies and infections.
Respiratory
- Seasonal allergic rhinitis during late-summer Pleosporales spore peaks
- Asthma exacerbations in sensitized asthmatics on high-count outdoor days
- Symptoms indistinguishable from Alternaria/Bipolaris seasonal allergy
- Thunderstorm-related spore fragmentation increasing respirable particles
Ocular
- Allergic conjunctivitis during outdoor peak season
- Itchy watery eyes on high-spore late-summer afternoons
- Periorbital swelling in sensitized individuals
Dermal
- Atopic dermatitis flares correlating with outdoor Pleosporales spore peaks
- Non-specific skin pruritus during high-count periods
- Skin irritation in patients with high-titer polysensitization
Systemic
- Fatigue from chronic mold-season allergen exposure
- Sleep disruption from uncontrolled rhinitis
- Reduced outdoor tolerance in sensitized patients during late summer
- Malaise correlating with high outdoor Pleosporales spore loads
When patients come in with a 'Spondylocladium positive' from an older panel, I explain that this is essentially a Bipolaris or Drechslera result by modern taxonomy — and that it belongs in the same Pleosporales clinical category as Alternaria. The treatment pathway is Alternaria-anchored SCIT. There is no separate 'Spondylocladium shot', and the name on the panel should not send patients on a diagnostic odyssey for a separate allergen.
When & Where Spondylocladium Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: late summer through early fall, paralleling the broader Pleosporales (Alternaria/Bipolaris) seasonal pattern· Approximately 10-12 weeks of meaningful outdoor spore loads in temperate regions
US Exposure Map
8 high-intensity statesWhat Spondylocladium Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Spondylocladium's modern taxonomic reassignment to Bipolaris/Drechslera/Pleosporaceae means its allergen cross-reactivity profile parallels these genera — with Alternaria providing the primary cross-reactivity framework via Alt a 1 homologues and Alt a 4 (PDI).
Primary Pleosporaceae family cross-reactivity; Alternaria is the SCIT evidence anchor for any Spondylocladium result
Is SCIT Right for Your Spondylocladium Allergy?
Answer five questions to assess whether your Spondylocladium (Pleosporales) sensitization warrants Alternaria-based SCIT evaluation.
How severe are your late-summer outdoor mold allergy symptoms?
The Spondylocladium SCIT Protocol
Spondylocladium sensitization is managed via Alternaria-based SCIT — there is no separate Spondylocladium vial in clinical practice. This genus is treated as a confirmatory Pleosporales finding pointing to the Alternaria evidence-based therapy pathway.
Weekly escalating doses of non-standardized Alternaria extract with a 30-minute observation period. Mold vials separated from pollen extracts. Pre-injection peak flow measurement recommended given Pleosporales-asthma severity association (O'Hollaren 1991).
Monthly or every-2-4-week maintenance injections. Clinical response and rAlt a 1 component monitoring guide duration decisions.
Discontinuation evaluation after 3-5 years of successful maintenance per standard Alternaria SCIT protocol.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Spondylocladium SCIT
No SCIT RCT exists for Spondylocladium. Pleosporaceae family-level evidence from Alternaria DBPC-RCTs is the operative framework.
- Alternaria SCIT: Combined symptom-medication score reduction (family-level Pleosporales proxy)63%Kuna et al., J Allergy Clin Immunol 2011, N=111 children, DBPC-RCT
- Alternaria SCIT: Improvement after 1 year with native Alt a 140%Tabar et al., J Allergy Clin Immunol 2019, DBPC-RCT
No Spondylocladium-specific SCIT RCT has been published. Modern taxonomy has largely reassigned Spondylocladium to Bipolaris/Drechslera in the Pleosporaceae, making Alternaria DBPC-RCT evidence (Kuna 2011: 63.5% combined score reduction; Tabar 2019) the operative framework. Component testing with rAlt a 1 confirms primary Pleosporales sensitization before SCIT initiation.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Spondylocladium SCIT Side Effects
Side effects follow standard Alternaria-based mold SCIT parameters, with mold extracts carrying higher local reaction rates than pollen extracts due to protease content.
Local reactions
4 documentedSystemic reactions
4 documentedWith Curex at-home mold SCIT, a prescribed epinephrine auto-injector is confirmed on hand before the first injection, the first dose and every dose change are supervised live over Zoom by a board-certified allergist, and the serum is sterile-compounded to USP <797>. Patients with asthma still complete a pre-injection peak-flow check before each dose.
SCIT vs Alternatives for Spondylocladium
Management options for Spondylocladium/Pleosporales sensitization are the same as for Alternaria sensitization: at-home SCIT through Curex, generic SLIT drops, environmental controls, or pharmacotherapy.
| Criterion | SCIT (Alternaria-based)Best | SLIT drops (generic) | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | 63% combined score reduction (Kuna 2011) for Pleosporales | Alternaria SLIT shows improvement (Cortellini 2010) | Partial — outdoor Pleosporales spores difficult to avoid | Symptomatic control only |
| 5-yr cost | $3,500-$8,000 over 5 years | $500-$2,000/yr | HEPA $100-$500/yr | $500-$2,000/yr ongoing |
| Duration | 3-5 years | 3-5 years | Ongoing | Ongoing |
| Convenience | At-home self-injection; weekly then monthly | Daily at-home use | Lifestyle modifications | Daily pills/sprays |
| Safety | Systemic reactions <1%; Zoom-supervised dosing | Lower systemic reaction risk | No injection risks | Drug side effects long-term |
| Lasting effect | Yes — tolerance may persist after treatment | Evidence less robust for molds than pollens | No lasting desensitization effect | No lasting effect |
SCIT (Alternaria-based)Best
SLIT drops (generic)
Avoidance
Medications
Alternaria-based SCIT is the best-evidenced immunotherapy for Pleosporales sensitization including Spondylocladium. Curex translates legacy mold panel names into modern Pleosporaceae sensitization interpretation and delivers Alternaria-based immunotherapy as an at-home allergy shot at $129/month all-inclusive: a serum compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first dose plus every dose change supervised live over Zoom by a board-certified allergist — discuss with your allergist as part of the overall treatment plan.
What Spondylocladium SCIT Actually Costs
Most major insurers cover mold SCIT under standard allergy benefits when ordered by a board-certified allergist. Verify your specific plan's allergy benefit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your spondylocladium allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Spondylocladium SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Spondylocladium is a legacy taxonomic name from historical mycology that persists in older allergy extract catalogs from manufacturers including Greer and Hollister-Stier. The name was applied to dematiaceous hyphomycetes with verticillate (whorled) conidiophores, but modern molecular phylogenetics — particularly the Manamgoda 2012 systematic study in Studies in Mycology — reassigned most of these isolates to Bipolaris, Drechslera, or related Pleosporaceae genera. Your panel result is real and clinically meaningful as a Pleosporales sensitization signal; the name 'Spondylocladium' on the report is simply a legacy label that your allergist will translate into modern Pleosporaceae terminology and the Alternaria-based SCIT pathway it implies.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.